MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION
Publication
, Conference
ODDONE, EZ; COWPER, P; MATCHAR, D; HAMILTON, J; HARTIGAN, P; SIMBERKOFF, M; FEUSSNER, J
Published in: CLINICAL RESEARCH
1992
Duke Scholars
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
1992
Volume
40
Issue
2
Start / End Page
A568 / A568
Citation
APA
Chicago
ICMJE
MLA
NLM
ODDONE, E. Z., COWPER, P., MATCHAR, D., HAMILTON, J., HARTIGAN, P., SIMBERKOFF, M., & FEUSSNER, J. (1992). MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION. In CLINICAL RESEARCH (Vol. 40, pp. A568–A568).
ODDONE, E. Z., P. COWPER, D. MATCHAR, J. HAMILTON, P. HARTIGAN, M. SIMBERKOFF, and J. FEUSSNER. “MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION.” In CLINICAL RESEARCH, 40:A568–A568, 1992.
ODDONE EZ, COWPER P, MATCHAR D, HAMILTON J, HARTIGAN P, SIMBERKOFF M, et al. MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION. In: CLINICAL RESEARCH. 1992. p. A568–A568.
ODDONE, E. Z., et al. “MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION.” CLINICAL RESEARCH, vol. 40, no. 2, 1992, pp. A568–A568.
ODDONE EZ, COWPER P, MATCHAR D, HAMILTON J, HARTIGAN P, SIMBERKOFF M, FEUSSNER J. MARKOV PROCESS COST-EFFECTIVENESS OF EARLY VERSUS LATER ZIDOVUDINE (AZT) TREATMENT OF SYMPTOMATIC HIV-INFECTION. CLINICAL RESEARCH. 1992. p. A568–A568.
Published In
CLINICAL RESEARCH
ISSN
0009-9279
Publication Date
1992
Volume
40
Issue
2
Start / End Page
A568 / A568